Get the Stockscreener App
1.21
0.83%
0.01
Intelligent Bio Solutions Inc stock is traded at $1.21, with a volume of 142.49K.
It is up +0.83% in the last 24 hours and down -1.63% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
See More
Previous Close:
$1.20
Open:
$1.19
24h Volume:
142.49K
Relative Volume:
0.80
Market Cap:
$9.23M
Revenue:
$3.19M
Net Income/Loss:
$-10.42M
P/E Ratio:
-0.0341
EPS:
-35.4757
Net Cash Flow:
$-10.65M
1W Performance:
-11.03%
1M Performance:
-1.63%
6M Performance:
-25.77%
1Y Performance:
-51.01%
1-Day Range:
$1.17
$1.25
1-Week Range:
$1.1001
$1.38
52-Week Range:
$1.00
$3.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-233-6971
Address
135 W 41ST ST,, NEW YORK
Compare INBS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.21 | 9.23M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions (NASDAQ: INBS) Is ‘One to Watch’ - The Globe and Mail
Intelligent Bio Solutions (INBS) Expands Global Presence with Ne - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multiling - GuruFocus
Intelligent Bio Solutions (INBS) Expands Global Presence with New Websites | INBS Stock News - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - The Manila Times
Intelligent Bio Solutions Targets $1.1B Market with Global Drug Testing Expansion in Arabic, Spanish Markets - Stock Titan
Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Given Average Rating of “Hold” by Analysts - American Banking and Market News
Intelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand Reach - Nasdaq
Intelligent Bio Solutions (INBS) Expands Language Options in Dru - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - The Manila Times
Intelligent Bio Solutions Expands Drug Screening Reach: Eyes Massive $1.1B Latin American Market Opportunity - Stock Titan
XTX Topco Ltd Buys New Position in Credit Acceptance Co. (NASDAQ:CACC) - American Banking and Market News
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - The Globe and Mail
Intelligent Bio Solutions (NASDAQ:INBS) Trading Up 7% – Time to Buy? - Defense World
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win - MSN
U.S. Patent Granted to Intelligent Bio Solutions for Drug Screening Tech - Medical Product Outsourcing
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - The Manila Times
Major Market Expansion: Drug Screening Tech Now Reaches 450 Million Arabic Speakers - Stock Titan
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - The Manila Times
Game-Changing Drug Testing Technology: Non-Invasive Solution Poised for Major US Launch - Stock Titan
MasterCard : Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - MarketScreener
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - The Manila Times
Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra - MarketScreener
Major Expansion: Intelligent Bio Solutions Captures $448M Spanish Drug Testing Market with 1,000 Monthly Orders - Stock Titan
US patent granted for INBS’ fingerprint drug screening technology - Yahoo
Intelligent Bio Solutions secures new U.S. patent By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Secures U.S. Patent for Drug Screening - TipRanks
Intelligent Bio Solutions secures new U.S. patent - Investing.com
Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge - Marketscreener.com
Revolutionary Fingerprint Drug Test Secures Game-Changing Patent for 2025 US Launch - Stock Titan
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology - Benzinga
Intelligent Bio Solutions On Track For 2025 U.S. Launch Of FDA-Cleared Fingerprint Drug Test - Nasdaq
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - The Manila Times
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch - TradingView
Revolutionary Drug Screening System Achieves 94% Accuracy in FDA Submission Data - Stock Titan
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch - Benzinga
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval - TipRanks
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 - The Globe and Mail
Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology - Marketscreener.com
Intelligent Bio Solutions Inc. Announces Anticipated Sixth Patent for Lateral Flow Technology in Drug Testing Solution - Nasdaq
Intelligent Bio Solutions set to secure new US patent - Investing.com
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - The Manila Times
Revolutionary Fingerprint Drug Test Patent Strengthens Intelligent Bio Solutions Market Position - Stock Titan
Intelligent Bio Solutions to Offer Additional Common Stock By Investing.com - Investing.com Australia
Intelligent Bio Solutions to Offer Additional Common Stock - Investing.com
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - The Manila Times
Intelligent Bio Solutions Reveals Growth Strategy at Elite Investor Conference March 25 - StockTitan
Intelligent Bio Solutions closes public offering of common stock - Medical Buyer
Intelligent Bio Solutions Inc (INBS) Should Be Considered For The Next Few Weeks - Stocks Register
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):